A coimmunization vaccine of Aβ42 ameliorates cognitive deficits without brain inflammation in an Alzheimer’s disease model
Shuang Wang(Dalian Medical University), Bin Wang(Southwest University of Science and Technology), Xiaoping Xie(Shantou University), Christoph Kaether(Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)), Yanxin Hu(Hubei Water Resources Research Institute), Xiaolin Li(Guangzhou University of Chinese Medicine), Dongmei Wang(Chengdu University of Traditional Chinese Medicine), Li Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chaofan Li(Carter Center), Lianfeng Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuang Geng(Shanghai Medical College of Fudan University), Bing Wu(China Agricultural University), Yang Yu(Obstetrics and Gynecology Hospital of Fudan University), Hanqian Xu(China Agricultural University)
Cited by 10
Related Papers
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
|Science Translational Medicine|2014|373
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
|Science Immunology|2022|366
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
|The Journal of Experimental Medicine|2014|353
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
|Science Translational Medicine|2013|267
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults
|JAMA Dermatology|2022|265